# Real-world performance of the AI diagnostic system IDx-DR in the diagnosis of diabetic retinopathy and its main confounders

**Authors:** Elisabeth Hunfeld, Allam Tayar, Sebastian Paul, Broder Poschkamp, Rico Großjohann, Eva Morawiec-Kisiel, Beathe Bohl, Johanna M. Pfeil, Martin Busch, Merlin Dähmcke, Tara Brauckmann, Sonja Eilts, Marie-Christine Bründer, Milena Grundel, Bastian Grundel, Frank Tost, Jana Kuhn, Jörg Reindel, Petra Augstein, Wolfgang Kerner, Andreas Stahl

PMC · DOI: 10.1038/s41598-026-36970-9 · Scientific Reports · 2026-01-29

## TL;DR

This study evaluates how well the AI system IDx-DR detects diabetic retinopathy in real-world settings and identifies factors that affect its performance.

## Contribution

The study provides real-world validation of IDx-DR's performance and identifies key confounders affecting its diagnostic accuracy.

## Key findings

- IDx-DR achieved high sensitivity and specificity in detecting severe diabetic retinopathy when image quality was sufficient.
- Factors like pupil size and patient age significantly impacted image acquisition and analyzability.
- IDx-DR results matched ophthalmologists' diagnoses in about half of the cases with good-quality images.

## Abstract

The escalating prevalence of diabetes mellitus (DM) emphasizes the critical need for early detection of diabetic retinopathy (DR). This study assesses the performance of the autonomous AI-based diagnostic system IDx-DR in detecting DR and its associated confounders in a real-world clinical setting. This prospective cross-sectional study involved 875 diabetic patients with a mean age of 52 years (range: 8–92). Retinal images were captured by trained assistants. IDx-DR results were compared with mydriatic fundus examination (gold standard) and Ophthalmologists’ image analysis. Factors impacting image acquisition or analyzability were examined. Among all patients, 10.5% yielded no image in miosis, and 26.1% were unanalyzable by IDx-DR. Confounders affecting image acquisition were examiner, pupil size, patient age and patients’ visual acuity. When good quality images were achieved, IDx-DR performed well, particularly in detection of severe DR (sensitivity 94.4%; specificity 90.5%). IDx-DR results exactly matched Ophthalmologists’ mydriatic fundoscopy gradings in 54.2% if images of sufficient quality were obtainable. Undergrading of DR severity by IDx-DR was rare (4.8%). IDx-DR shows promise in detecting DR, especially in resource-limited settings and in detecting severe DR. One remaining challenge is good image acquisition in miotic patients.

The online version contains supplementary material available at 10.1038/s41598-026-36970-9.

## Linked entities

- **Diseases:** diabetes mellitus (MONDO:0005015), diabetic retinopathy (MONDO:0005266)

## Full-text entities

- **Genes:** VEGFA (vascular endothelial growth factor A) [NCBI Gene 7422] {aka L-VEGF, MVCD1, VEGF, VPF}, INS (insulin) [NCBI Gene 3630] {aka IDDM, IDDM1, IDDM2, ILPR, IRDN, MODY10}
- **Diseases:** pupil dilation (MESH:D011681), blindness (MESH:D001766), mydriasis (MESH:D015878), angle-closure glaucoma (MESH:D015812), type 1 diabetes (MESH:D003922), DM (MESH:D003920), COVID-19 (MESH:D000086382), DR (MESH:D003930), type 2 diabetes (MESH:D003924), miosis (MESH:D015877), impaired view of the retina (MESH:D019572), diabetic macular edema (MESH:D008269), retinopathy (MESH:D058437), cataract (MESH:D002386)
- **Chemicals:** IDx (-)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12864748/full.md

## Figures

6 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12864748/full.md

## References

6 references — full list in the complete paper: https://tomesphere.com/paper/PMC12864748/full.md

---
Source: https://tomesphere.com/paper/PMC12864748